Clinical Trial Update: COlchicine in Moderate-severe Hospitalized Patients Before ARDS to Treat COVID-19 [Phase 2]

View source ↗

Summary

Phase 2 clinical trial investigating colchicine in moderate-to-severe hospitalized COVID-19 patients before ARDS; study terminated with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronavirus Infection

Drugs mentioned

• COLCHICINE (Colchicine)

Snippet

Sponsor: Maimonides Medical Center | Conditions: Coronavirus Infection | Phase 2 | Status: TERMINATED | Results posted: 2022-02-18